ACBM
Acro Biomedical Co., Ltd.
$0.03
+0.00 (+0.00%)
At close · Jul 3
Market Cap
$1.56M
Shares
60,042,000
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.03
Day$0.03–0.03
52W$0.00–0.10
Avg vol 30d17
Short int4 · 0.0% float · 1000.0d
DataJan 2020–Jul 2026
Filing10-Q · May 5
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+60% above
◦
Price vs 50-day avg
0% above
−
RSI (14)
100 · overbought
−
MACD trend
negative
◦
52-week position
25% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $0 › 200d $0 — 50d above 200d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
◦
Short interest
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 5, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+60% above
Bullish
Price vs 50-day avg
0% above
Neutral
RSI (14)
100 · overbought
Bearish
MACD trend
negative
Bearish
52-week position
25% · mid-range
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 25%
52-wk high $0
vs 200-day avg +60%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACBM
this stock
Acro Biomedical Co., Ltd.
|
$1.56M | +17.1% | — | — | 0.0% |
|
CNDA
Concord Acquisition Corp II
|
$61.46B | +0.0% | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | +0.0% | — | 100.2 | — |
|
XXI
Twenty One Capital, Inc.
|
$3.53B | -38.1% | — | — | 0.9% |
|
WELNF
Integrated Wellness Acquisition Corp
|
$1.93B | +0.0% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACBM | +0.0% | +0.0% | +17.1% | +0.0% | +17.1% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.4% | +1.3% | +9.1% | +0.3% | +7.9% |